Related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES
Thursday 11 October 2012
  • APEX Medical
  • Performance
    The company's stock price closed at NT$29.25 on the TSE on Tuesday, April 24, 2018.
    The company has reported consolidated revenues of NT$202 million for March 2018, representing a 42.3% increase on month and 0.7% increase on year.
    For the fourth quarter of 2017, the company totaled NT$512 million in consolidated revenues, down 9.6% sequentially and down 2.7% on year.
    Brief

    Full name: APEX Medical

    Chinese name: 雃博股份有限公司

    Short name: Apex

    Stock code: 4106

    Tax ID: 23632773

    Market: TSE

    Established: 17 Mar 1990

    Paid in capital: NT$833.86 million

    Listed on TSE: 8 Nov 2004

    Listed on OTC: 22 Jan 2002

    Listed on ESB: 2 Jan 2002

    Public since: 19 Jul 1999

    Website: cht.apexmedical.com.tw

  • Latest stock
    Apex [4106] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    25-Apr 744 456 22,402,710 29.25 30.60 29.25 30.45+1.20+4.10% 30.35 30.45
    24-Apr 132 89 3,895,800 29.80 30.00 29.25 29.25-0.65-2.17% 29.25 29.30
    23-Apr 171 107 5,074,750 29.65 29.95 29.50 29.90+0.60+2.05% 29.85 29.95
    20-Apr 78 48 2,291,100 29.35 29.50 29.30 29.30+0.00+0.00% 29.30 29.45
    19-Apr 153 106 4,509,950 29.25 29.90 29.25 29.30+0.25+0.86% 29.30 29.45
    18-Apr 149 85 4,351,850 29.50 29.50 29.00 29.05-0.25-0.85% 29.00 29.05
    17-Apr 240 138 7,032,550 30.00 30.00 29.00 29.30-0.60-2.01% 29.30 29.35
    16-Apr 169 100 5,065,750 30.00 30.10 29.80 29.90-0.10-0.33% 29.85 29.95
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Mar 2017 - Mar 2018 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Mar-18

    202

    42.3%

    0.7%

    499

    6.5%

    Feb-18

    142

    (8.3%)

    3.9%

    297

    10.8%

    Jan-18

    155

    (12.2%)

    18%

    155

    18%

    Dec-17

    177

    (2.2%)

    (12.7%)

    2,090

    5.1%

    Nov-17

    181

    16.5%

    8.6%

    1,913

    7.1%

    Oct-17

    155

    (7.4%)

    (0.7%)

    1,732

    6.9%

    Sep-17

    167

    (20.6%)

    22.2%

    1,577

    7.7%

    Aug-17

    211

    12.2%

    38%

    1,410

    6.2%

    Jul-17

    188

    6.4%

    34.3%

    1,199

    2.1%

    Jun-17

    176

    (11.9%)

    1%

    1,011

    (2.3%)

    May-17

    200

    20.9%

    16.4%

    835

    (2.9%)

    Apr-17

    166

    (17.5%)

    (7.7%)

    635

    (7.8%)

    Mar-17

    201

    46.7%

    13.5%

    469

    (7.8%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2018

    Apex: Consolidated revenues, 4Q16 - 4Q17 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    4Q-17

    512

    (9.6%)

    (2.7%)

    2,089

    5%

    3Q-17

    566

    4.5%

    31.8%

    1,577

    7.7%

    2Q-17

    542

    15.6%

    3%

    1,011

    (2.3%)

    1Q-17

    469

    (10.8%)

    (7.8%)

    469

    (7.8%)

    4Q-16

    526

    22.4%

    (0.8%)

    1,990

    (1.3%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2018

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 4Q16 - 4Q17 (NT$k)

    Item

    4Q-2017

    3Q-2017

    2Q-2017

    1Q-2017

    4Q-2016

    Current assets

    1,284,144

    1,308,761

    1,338,039

    1,233,710

    1,268,131

    Intangible assets

    445,378

    446,802

    420,386

    415,497

    432,513

    Non-current assets

    1,300,150

    1,304,102

    1,317,025

    1,273,566

    1,322,918

    Assets

    2,584,294

    2,612,863

    2,655,064

    2,507,276

    2,591,049

    Current liabilities

    674,839

    718,649

    804,349

    678,421

    738,224

    Non-current liabilities

    301,266

    297,752

    296,389

    295,241

    294,782

    Liabilities

    976,105

    1,016,401

    1,100,738

    973,662

    1,033,006

    Stockholders' equity

    1,608,189

    1,596,462

    1,554,326

    1,533,614

    1,558,043

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2018

    Apex: Consolidated income statement, 4Q16 - 4Q17 (NT$k)

    Item

    4Q-2017

    3Q-2017

    2Q-2017

    1Q-2017

    4Q-2016

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

    0

     

     

     

     

     

    469,035

     

    0

     

    Operating revenue

    511,812

     

    566,344

     

    542,086

     

    469,035

     

    525,757

     

    Gross profit (loss) from operations

    212,357

     

    235,788

     

    246,958

     

    211,420

     

    217,533

     

    Operating expenses

    205,187

     

    196,531

     

    182,293

     

    170,935

     

    188,896

     

    Operating income (loss)

    7,170

     

    39,257

     

    64,665

     

    40,485

     

    28,637

     

    Non-operating expenses and losses

    5,585

     

    1,814

     

    -3,328

     

    -3,882

     

    -8,381

     

    Income from continuing operations before income tax

    12,755

     

    41,071

     

    61,337

     

    36,603

     

    20,256

     

    Net income (loss)

    20,034

     

    22,938

     

    48,498

     

    26,213

     

    15,624

     

    Diluted earnings per share (NT$)

    0.2

     

    0.3

     

    0.5

     

    0.3

     

    0.2

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2018

  • APEX Medical full profile
Realtime news

Global server market – 4Q 2017

Taiwan LCD monitors – 4Q 2017

Taiwan handsets – 4Q 2017

Global AP market, 2017-2021

Taiwan server shipment forecast and industry analysis, 2018

China AMOLED panel capacity expansion forecast, 2016-2020

© DIGITIMES Inc. All rights reserved.
Please do not republish, publicly broadcast or publicly transmit content from this website without written permission from DIGITIMES Inc. Please contact us if you have any questions.